Atrial fibrillation (AF) is a major source of morbidity in patients and cost to the health care community. In the presence of risk factors for thromboembolism, AF is associated with an increased risk of stroke, and this risk is reduced with warfarin. However, warfarin has limitations, including the risk of bleeding and the need for regular blood tests. The
Chelation therapy for cardiovascular disease; statins and kidney injuries; chlorthalidone for hypertension; and FDA actions.
The frequency of isolation of carbapenem-resistant Enterobacteriaceae is increasing in the U.S., with the highest prevalence in the northeastern region.
Mediterranean diet can reduce risk for stroke
The Rate Control Efficacy in Permanent Atrial Fibrillation (RACE II) trial compared strict rate control vs lenient rate control in patients with permanent atrial fibrillation.
The risk of hip fracture goes up for about 6 weeks immediately after older people start taking antihypertensives.
